
Results 1 - 20 of 4,844 in Parkinson's Disease
Proteostasis Therapeutics Presents Preclinical Data on Parkinsona s...
Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today presented data on the Company's preclinical targets for Parkinson's disease and cystic fibrosis at a conference hosted by the European Molecular Biology ... (more) Comment?
Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study
... CERE-120 is a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease. This exploratory analysis identified a more robust response to CERE-120 in Parkinson's patients diagnosed within 5 years prior to ... Comment?
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen...
... enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis. This press release contains "forward-looking" statements, including, ... Comment?
... to treat anything from heart disease and spinal cord injuries to major neurological diseases, like Parkinson's disease and multiple sclerosis. Through a common laboratory method known as somatic cell nuclear transfer (SCNT), ONPRC scientists, along ... Comment?
Impax board steps in to oversee Hayward manufacturing issues
Stung by problems at its Hayward manufacturing plant that led federal regulators not to approve a treatment for Parkinson's disease symptoms, Impax Laboratories Inc. Comment?
UAB looking for people to take a scratch-and-sniff test for Parkinson's disease study
BIRMINGHAM, Alabama -- Losing your sense of smell might be a risk factor for developing Parkinson's disease and to that end the University of Alabama at Birmingham is part of a worldwide effort to sniff out the answers. Comment?
Impax Board of Directors Establishes Compliance Committee
... Company's New Drug Application for an investigational drug, RYTARYTM, for the treatment of idiopathic Parkinson's disease. The Committee will also provide oversight for the Company's Quality Improvement Program (QIP) with respect to change ... Comment?
ACADIA Pharmaceuticals Announces Exercise in Full of Option to...
... pipeline of product candidates led by pimavanserin, which is in Phase III development as a treatment for Parkinson's disease psychosis. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and ... Comment?
XenoPort, Inc. Drops Multiple Sclerosis Drug After Trial Failure
... enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis. This press release contains "forward-looking" statements, including, ... Comment?
ReNeuron Group plc (RENE) - Pharmaceuticals & Healthcare - Deals and...
It develops stem cell therapies for a range of neuro degenerative diseases and other conditions, including Parkinson's disease, Type 1 diabetes, and diseases of the retina. Comment?
Nashville Predators fire associate coach Peter Horachek
w/Photo
... coach, taking over the role of Brent Peterson, who left the position because of his battle with Parkinson's disease. Horachek had interviewed for NHL head coaching positions in the past, including with the Dallas Stars two years ago. In a late ... Comment?
Faux doe sews up a new life for Leanne
w/Photo
A former firefighter who had to give up her job when she was diagnosed with Parkinson's disease has sewn up a new career. Comment?
Diabetes drug tested in Parkinson's disease patients
Parkinson's disease is a degenerative neurological disorder marked by a progressive loss of motor control. Comment?
Human Cloning Breakthrough Prompts Religious Objections
... argue there are other ethical techniques for creating stem cells that may help cure illnesses like Parkinson's disease and diabetes and that the alternatives do not require cloning human embryos or destroying them. The most popular alternative is ... Comment?
ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index
... led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two ... Comment?
Wolters Kluwer Health receives 13 awards from the ASHPE
... Department - OR Nurse . Gold: Neurology Now , "Rocket Man: Astronaut Rich Clifford's Journey with Parkinson's Disease" (April/May 2012), Published on behalf of the American Academy of Neurology (AAN) Bronze: Neurology Today , "Elevated Mortality ... Comment?
DNA key to breast cancer in spotlight
... breast cancer, which could be important to his teenage daughter. He also carried a mutation linked with Parkinson's disease, which his mother had. But while the threat of breast cancer can be treated with screening, drugs or surgery, there is no ... Comment?
Tanner to open $1.3M rehab facility
... amputees, traumatic injury patients and those with neurological diseases, such as multiple sclerosis and Parkinson's disease. It will also be used for younger patients recovering from physical trauma, such as caused by automobile accidents or sports ... Comment?
Too Many Questions Make This Thursday Mover a Sell
... a market that has no established size, due to it being a large unmet need. Its drug Primavanserin treats Parkinson's disease psychosis, which represents 40% of those with Parkinson's disease, thus having peak sales estimates of $1 billion (with both ... Comment?
'Popcorn Friday' proceeds aid retired Milton teacher
w/Photo
... 20 E. Madison Ave., Milton, WI 53563. Today, the retired teacher can no longer eat popcorn because Parkinson's disease has left the muscles in his mouth and throat too weak to swallow it. In May, middle school students are helping the longtime ... Comment?